# Neil Devani

> Neil Devani is a seed investor at Necessary Ventures backing Health Care and Biotechnology. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Necessary Ventures](https://shizune.co/investors/profile/necessary-ventures)
- Location: San Francisco, United States
- Total investments: 6
- Last investment: May 2024
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/neildevani
- X (Twitter): https://twitter.com/neildevani
- Website: http://www.neildevani.com

Neil Devani is a seed investor at Necessary Ventures in San Francisco focused on Health Care and Biotechnology. Neil invests in companies that improve people's lives. He primarily focuses on deep tech companies and those in the healthcare, climate, and fintech.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 50% |
| Biotechnology | 2 | 33% |
| Energy | 1 | 17% |
| Medical | 1 | 17% |
| Robotics | 1 | 17% |

20 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 50% |
| Pre-Seed | 1 | 17% |
| Series A | 1 | 17% |
| Series B | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Plural Energy | Plural Energy helps investors invest directly in renewable energy projects. The company utilizes blockchain-enabled smart contracts to provide constant yield and liquidity to investors. | $2.3M | Pre-Seed | May 30, 2024 |  |
| Rubi Laboratories | Rubi Laboratories develops biocatalyst solutions that manufacture carbon-negative textiles for the fashion industry. Its technology offers a natural resource for making things and directly synthesizes the threads that help clients produce viscose that is carbon-negative, water-chemical, land-neutral, traceable, and biodegradable. | $4.5M | Seed | Feb 16, 2022 |  |
| Vicarious Surgical | Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goal of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. | $10M | Series A | Feb 14, 2019 |  |
| Decent | Decent offers more affordable healthcare by aligning incentives to improve health, reduce costs, and put members at the center of their care. | $8M | Seed | May 18, 2018 |  |
| Recursion Pharmaceuticals | Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS,that combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate our programs. We are a biotechnology company scaling more like a technology company. | $60M | Series B | Oct 04, 2017 |  |
| BenRevo | For employers who purchase health insurance, BenRevo is a platform that brings the shopping experience online. The current method of buying insurance used by brokers, employers and insurance carriers is paper heavy, error prone and time consuming. BenRevo simplifies this process by connecting all parties through a digital marketplace. And by doingso BenRevo will limit errors, imrove plans and price transparency, and automate the $185B mid market insurance space. | $1.5M | Seed | Jul 21, 2017 |  |

6 of 6 investments shown.

## Co-investors
- [Menlo Ventures](https://shizune.co/investors/profile/menlo-ventures) — VC Fund, 2 deals together
- [AngelList](https://shizune.co/investors/profile/angellist) — VC Fund, 1 deal together
- [Axial VC](https://shizune.co/investors/profile/axial-vc) — VC Fund, 1 deal together
- [CapitalX](https://shizune.co/investors/profile/capitalx) — VC Fund, 1 deal together
- [Climate Capital](https://shizune.co/investors/profile/climate-capital) — VC Fund, 1 deal together
- [Collaborative Fund](https://shizune.co/investors/profile/collaborative-fund) — VC Fund, 1 deal together

## About Necessary Ventures

VC Fund · San Francisco, United States

Necessary Ventures focuses on investing in what the world needs. They work with the founders to build the most scalable solutions.

1 contacts available at Necessary Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Neil Devani | Founder and Managing Partner | https://shizune.co/investors/profile/neil-devani |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Neil Devani invest in?

Neil Devani invests primarily in Health Care, Biotechnology and Energy startups, most often at Seed and Pre-Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Neil Devani last invest?

The most recent investment recorded for Neil Devani closed in May 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co